3rd Circ. Revives Eyedrop Users' Action Over Dosage Size
The Third Circuit on Wednesday revived a putative class action accusing Merck and other drug companies of boosting eyedrop sales by using bottles that dispense larger-than-needed doses, saying the suing consumers...To view the full article, register now.
Already a subscriber? Click here to view full article